Wayland Group Corp (MRRCF)
0.00
USD |
OTCM |
May 31, 16:00
Wayland Group Total Assets (Quarterly): 95.53M for June 30, 2018
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 119.99M |
| June 30, 2018 | 95.53M |
| March 31, 2018 | 99.48M |
| December 31, 2017 | 74.22M |
| September 30, 2017 | 22.45M |
| June 30, 2017 | 19.21M |
| March 31, 2017 | 20.64M |
| December 31, 2016 | 18.26M |
| September 30, 2016 | 0.0004M |
| June 30, 2016 | 0.0004M |
| Date | Value |
|---|---|
| March 31, 2016 | 0.0004M |
| December 31, 2015 | 0.0004M |
| September 30, 2015 | 0.0011M |
| June 30, 2015 | 0.0008M |
| March 31, 2015 | 0.0008M |
| December 31, 2014 | 0.0009M |
| September 30, 2014 | 0.0016M |
| June 30, 2014 | 0.0008M |
| December 31, 2013 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.24M |
| Shareholders Equity (Quarterly) | 74.29M |